Removing Barriers to Colorectal Cancer Screening Act of 2020

Removing Barriers to Colorectal Cancer Screening Act of 2020

This bill modifies cost-sharing requirements for colorectal cancer screening tests, and drug manufacturer reporting requirements, under Medicare medical services.

Specifically, the bill waives coinsurance requirements with respect to colorectal cancer screening tests, regardless of the code billed for a resulting diagnosis or procedure. The bill phases in implementation over an eight-year period.

Additionally, manufacturers of covered drugs that do not have rebate agreements under the Medicaid Drug Rebate Program must report similar information as is required under the program, including average sales price, total units, and wholesale acquisition cost. Manufacturers that fail to comply or that report false information are subject to civil penalties.

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1570 Introduced in House (IH)]

<DOC>






116th CONGRESS
  1st Session
                                H. R. 1570

 To amend title XVIII of the Social Security Act to waive coinsurance 
  under Medicare for colorectal cancer screening tests, regardless of 
   whether therapeutic intervention is required during the screening.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             March 6, 2019

Mr. Payne (for himself, Mr. Rodney Davis of Illinois, Mr. McEachin, Mr. 
McKinley, Ms. Barragan, Mr. Bishop of Georgia, Mr. Brendan F. Boyle of 
Pennsylvania, Ms. Brownley of California, Mr. Cicilline, Mr. Courtney, 
  Mr. DeFazio, Ms. DeLauro, Mr. Deutch, Mrs. Dingell, Mr. Engel, Mr. 
    Evans, Mr. Foster, Ms. Gabbard, Mr. Gallego, Mr. Garamendi, Mr. 
Grijalva, Mr. Hastings, Mr. Heck, Mr. Higgins of New York, Ms. Hill of 
    California, Ms. Kelly of Illinois, Mr. Khanna, Mr. Kilmer, Mr. 
 Krishnamoorthi, Ms. Lee of California, Mr. Lipinski, Mr. Sean Patrick 
Maloney of New York, Ms. Matsui, Ms. McCollum, Ms. Moore, Mr. Moulton, 
Ms. Norton, Mr. O'Halleran, Mr. Panetta, Mr. Quigley, Miss Rice of New 
York, Mr. Ruppersberger, Ms. Speier, Ms. Wasserman Schultz, Mrs. Watson 
 Coleman, Mr. Van Drew, Mr. Babin, Mr. Collins of New York, Mr. Cook, 
   Mr. Fitzpatrick, Mr. Gianforte, Ms. Herrera Beutler, Mr. Hice of 
 Georgia, Mr. Hunter, Mr. Joyce of Ohio, Mr. Kelly of Mississippi, Mr. 
King of Iowa, Mr. Loudermilk, Mr. Mooney of West Virginia, Mr. Mullin, 
   Mr. Perry, Mr. Shimkus, Ms. Stefanik, Mr. Tipton, Mr. Turner, Mr. 
 Zeldin, Ms. DelBene, Ms. Clarke of New York, Mr. Gibbs, Miss Gonzalez-
Colon of Puerto Rico, Mr. Bera, Mr. Smith of Washington, Mr. Brindisi, 
Ms. Fudge, Mr. Sires, Mr. Nadler, Mr. Takano, Ms. Velazquez, Mrs. Axne, 
 Mr. David Scott of Georgia, Ms. Schakowsky, Mr. Tonko, Mr. Larson of 
 Connecticut, Mr. Michael F. Doyle of Pennsylvania, Mr. Price of North 
   Carolina, Mr. Cisneros, Mr. Yarmuth, Mr. Keating, Mr. Lynch, Mr. 
 Sherman, Ms. Johnson of Texas, Mr. Larsen of Washington, Mr. Schiff, 
    Ms. Roybal-Allard, Mr. McNerney, Mr. Kustoff of Tennessee, Mr. 
   Butterfield, Mr. Espaillat, Mrs. Beatty, Mr. Suozzi, Mr. Scott of 
   Virginia, Mr. Pascrell, Ms. Adams, Mrs. Davis of California, Mr. 
   Morelle, Ms. Frankel, Mr. Jeffries, Mr. Clyburn, Ms. Waters, Mr. 
 Johnson of Georgia, Ms. Pressley, Mr. Danny K. Davis of Illinois, Mr. 
   Clay, Mr. Rush, Mr. Carson of Indiana, Mr. Meeks, Mr. Veasey, Mr. 
  Richmond, Ms. Bass, Mr. Brown of Maryland, and Mr. Green of Texas) 
 introduced the following bill; which was referred to the Committee on 
   Energy and Commerce, and in addition to the Committee on Ways and 
 Means, for a period to be subsequently determined by the Speaker, in 
   each case for consideration of such provisions as fall within the 
                jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
 To amend title XVIII of the Social Security Act to waive coinsurance 
  under Medicare for colorectal cancer screening tests, regardless of 
   whether therapeutic intervention is required during the screening.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Removing Barriers to Colorectal 
Cancer Screening Act of 2019''.

SEC. 2. FINDINGS.

    Congress finds the following:
            (1) Colorectal cancer is the second leading cause of cancer 
        death among men and women combined in the United States.
            (2) In 2019, more than 145,600 Americans will be diagnosed 
        with colorectal cancer and approximately 51,000 Americans will 
        die from it.
            (3) Approximately 60 percent of colorectal cancer cases and 
        70 percent of deaths occur in those aged 65 and older.
            (4) Colorectal cancer screening colonoscopy allows for the 
        detection and removal of polyps, or abnormal growths, that 
        could become cancerous, as well as for the early detection of 
        colorectal cancer when treatment can be most effective.
            (5) Although colorectal cancer is largely preventable, one 
        in three adults over 50 years of age are not up to date with 
        recommended colorectal cancer screening.
            (6) Over 1,700 organizations have committed to eliminating 
        colorectal cancer as a major public health problem and are 
        working toward the shared goal of reaching 80 percent screened 
        for colorectal cancer in every community.
            (7) Colorectal cancer screening colonoscopy is a highly 
        effective preventive service, and removing financial barriers 
        can help to increase screening rates.

SEC. 3. WAIVING MEDICARE COINSURANCE FOR COLORECTAL CANCER SCREENING 
              TESTS.

    (a) In General.--Section 1833(a)(1)(Y) of the Social Security Act 
(42 U.S.C. 1395l(a)(1)(Y)) is amended by inserting ``, including a 
colorectal cancer screening test (regardless of the code that is billed 
for the establishment of a diagnosis as a result of the test, or for 
the removal of tissue or other procedure that is furnished in 
connection with, as a result of, and in the same clinical encounter as 
the screening test),'' after ``section 1861(ddd)(3)''.
    (b) Effective Date.--The amendment made by this section shall apply 
to items and services furnished after the date of the enactment of this 
Act.
                                 <all>